Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News NexgenRx Inc V.NXG

Alternate Symbol(s):  NEGXF

Financial Services Asset Management
NexgenRx Inc. is a Canada-based independent full-service third-party administrator and technology solutions provider. The Company is focused on building technology platforms that equip its clients with unprecedented capabilities for managing and self-managing group benefit plans, group pension plans and patient support programs. It offers plan sponsors, providers and patient support program... see more

Recent & Breaking News (TSXV:NXG)

NexgenRx Announces 2024 Year End Results with Continued Strong Revenue Growth and Increasing Positive EBITDA

ACCESS Newswire 13 days ago

NexgenRx Announces Third Quarter Results and Declaration of Divdend

ACCESS Newswire November 25, 2024

NexgenRx Announces Director Re-Appointment

ACCESS Newswire October 7, 2024

NexgenRx Announces New Director

ACCESS Newswire October 1, 2024

NexgenRx Announces Second Quarter Results, With Over 19% Revenue Growth and Positive EBITDA

ACCESS Newswire August 15, 2024

NexgenRx Announces Share Issuances Under Consulting Agreement

ACCESS Newswire July 18, 2024

NexgenRx Announces Declaration of Dividend

ACCESS Newswire June 14, 2024

NexgenRx Announces First Quarter Results, with 24% Revenue Growth and Record Earnings

ACCESS Newswire May 17, 2024

NexgenRx Announces Annual Meeting Results

ACCESS Newswire May 16, 2024

NexgenRx Announces 2023 Year End Results With Solid Revenue Growth, Continuing Positive EBITDA

ACCESS Newswire April 5, 2024

NexgenRX Announces Declaration of Dividend

ACCESS Newswire December 20, 2023

NexgenRx Inc. Announces Q3 2023 Quarterly Results with Continued Revenue Growth and Positive EBITDA

ACCESS Newswire November 23, 2023

Nexgenrx Announces Q2 2023 Quarterly Results (With Continued Revenue Growth), Consulting Agreement and Option Grant

ACCESS Newswire August 21, 2023

TSX Venture Exchange Stock Maintenance Bulletins

Canada NewsWire June 16, 2023

NexgenRx Announces Declaration of Dividend

ACCESS Newswire June 15, 2023

NexgenRx Announces Q1 2023 Quarterly Results with Continued Revenue Growth and Positive EBITDA and Announces Election of New Director

ACCESS Newswire May 18, 2023

NexgenRx Announces 2022 Year End Results With Continued Revenue Growth And Positive EBITDA

ACCESS Newswire April 6, 2023

NexgenRx Announces Q3 2022 Financial Results with Continued Revenue Growth, Positive EBITDA and Free Cash Flow

ACCESS Newswire November 29, 2022

Nexgenrx Announces Declaration Of Dividend

ACCESS Newswire September 23, 2022

NexgenRx Announces Q2 2022 Financial Results with Continued Revenue Growth, Positive EBITDA and Increased Free Cash Flow

ACCESS Newswire August 18, 2022